Combatting Misinformation During the COVID-19 Pandemic Via Social Media
Keywords:COVID-19, Pandemic, Misinformation, Internet, Media
Misinformation or "fake news" has existed in society for quite a while, with healthcare related misinformation being especially problematic, particularly during the COVID-19 pandemic. Due to the false news circulating on the social media, many misconceptions exist about the disease and the pandemic, leading to people reacting in extreme and unrecommended ways that cause more harm than benefit. In order to combat this, the CMH Arts and Design Society took an initiative and formed a facebook page named "Pakistan Corona Virus Research Outlook" that aimed to present well researched facts regarding COVID-19 in the form of video or poster presentations, so that they could be understood easily by the general public. We also drafted an online handbook that addressed the basic concerns regarding the signs and symptoms of the disease, and the basic principles of management, so as to equip the people without medical knowledge with sufficient information for them to be able to manage mild symptoms themselves, without burdening the healthcare system. We also formed a facebook group by the name "Corona Virus (COVID-19) Free Counselling" that aimed to provide a platform to the public to ask their queries regarding COVID-19 which were then addressed by medical professionals. A post-COVID syndrome series was also initiated on these platforms that addressed the post-COVID symptoms individually and provided a follow up plan for each, based on expert guidelines.
World Economic Forum – Global Risks 2013 Eighth Edition [Internet]. Global Risks 2013. 2021. Available from: http://wef.ch/GJKqei. Cited February 8, 2021.
Wang Y, McKee M, Torbica A, Stuckler D. Systematic Literature Review on the Spread of Health-related Misinformation on Social Media. Soc Sci Med. 2019 Nov;240:112552.
Vrinten C, Gallagher A, Waller J, Marlow L. Cancer stigma and cancer screening attendance: a population based survey in England. BMC Cancer. 2019 Jun 11;19(1):566.
Leong A, Sanghera R, Jhajj J, Desai N, Jammu B, Makowsky M. Is YouTube Useful as a Source of Health Information for Adults With Type 2 Diabetes? A South Asian Perspective. Can J Diabetes. 2018 Aug;42(4):395-403.e4.
Wallen J, Gulland A, Newey S, Boycott-Owen M, Meaker M, Nuki P, et al. Coronavirus: Indian man 'died by suicide' after becoming convinced he was infected. The Telegraph. 2021. Available from: https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-indian-man-died-suicide-becoming-convinced-infected/. Cited February 8, 2021
Sadio A, Gbeasor-Komlanvi F, Konu R, Bakoubayi A, Tchankoni M, Bitty-Anderson A, et al. Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health. 2021 Jan 6;21(1):58.
Kasulis K. ‘Patient 31’ and South Korea’s sudden spike in coronavirus cases. Aljazeera.com. 2021. Available from: https://www.aljazeera.com/news/2020/03/31-south-korea-sudden-spike-coronavirus-cases-200303065953841.html?xif=. Cited February 8, 2021.
Thomas N. Utilizing Health Education and Promotion to Minimize the Impact of COVID-19. Int J Med Student. 2020 May-Ago;8(2):188-190.
Pakistan Corona Virus Research Outlook [Internet]. Facebook. 2021. Available from: https://www.facebook.com/coronaoutlookcmhlmc. Cited April 5, 2021.
Pakistan Coronavirus Research. Instagram. 2021. Available from: https://instagram.com/coronaoutlookcmhlmc?igshid=f797k2r479fr. Cited April 5, 2021.
Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerging Microbes & Infections. 2020 Dec;9(1):1123-30.
Rothan H, Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433.
Ortolani C, Pastorello E. Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost? Clin Mol Allergy. 2020 Sep 9;18:17
Corona Virus (COVID-19) Free Counselling. Facebook.com. 2021. Available from: https://www.facebook.com/groups/621038562095545. Cited April 5, 2021.
COVID-19 patient friendly ebook [Internet]. Facebook; 2021. Available from: https://www.facebook.com/groups/621038562095545. Cited April 5, 2021.
Mardani M. Post COVID Syndrome. Archives of Clinical Infectious Diseases. 2020;15(2):e108819
Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE, Nice.org.uk. 2021. Available from: https://www.nice.org.uk/guidance/ng188. Cited April 5, 2021.
How to Cite
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to email@example.com
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to firstname.lastname@example.org